647
Views
2
CrossRef citations to date
0
Altmetric
Review

Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation

&
Pages 773-788 | Received 04 Mar 2018, Accepted 14 Jul 2018, Published online: 26 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Thomas Sau-Yan Chan, Sally Shuk-Yee Cheng, Wei-Ting Chen, Danny Chung Hsu, Rene Wing-Yan Chau, Suk Hyun Kang, Adnan Alsumali & Yok-Lam Kwong. (2020) Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong. Journal of Medical Economics 23:12, pages 1485-1492.
Read now
Jackrapong Bruminhent & R.R. Razonable. (2020) Advances in drug therapies for cytomegalovirus in transplantation: a focus on maribavir and letermovir. Expert Opinion on Orphan Drugs 8:10, pages 393-401.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.